Peter von dem Borne

14PUBLICATIONS
79CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 22, 2026
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).

|Oct 20, 2025
Transplantation strategy affects the risk of GvHD after prophylactic and preemptive donor lymphocyte infusion.

Eva A S Koster, Peter A von dem Borne, Joost G K van der Hem

|Oct 18, 2025
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT.

Arnon Nagler, Jacques-Emmanuel Galimard, Sarah Kayser

|Mar 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT.

Jordi Esteve, Arnon Nagler, Myriam Labopin

|Feb 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT.

Jaime Sanz, Myriam Labopin, Jurjen Versluis

|Feb 05, 2025
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide.

Alexandros Spyridonidis, Myriam Labopin, Bipin P Savani

Pageof 3

Frequent Collaborators

7 joint publications

Mohamad Mohty

7 joint publications

Arnon Nagler

5 joint publications

Jaime Sanz

5 joint publications

Fabio Ciceri